Plain-English translation of NCT07178847 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This research trial is testing whether a simple blood test can detect cancer cells remaining in your body after you finish chemotherapy and radiation treatment for advanced head and neck cancer. Researchers want to know if circulating DNA (genetic material from cancer cells that leaks into the bloodstream) can be a reliable early warning sign. This could help doctors catch cancer sooner if it comes back.
After chemotherapy and radiation, doctors need a better way to know whether all the cancer is truly gone or if some cells are still present. Currently, doctors use imaging scans and physical exams, but these may not always catch tiny amounts of remaining disease. A simple blood test could provide an earlier and easier detection method.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will have two blood draws during your follow-up care after finishing chemotherapy and radiation—one at 1 month and another at 3 months after your treatment ends. Each blood sample is quick and routine. Researchers will then analyze your blood for circulating DNA and compare the results with imaging scans and physical exams your doctors perform to see if the blood test can reliably detect any remaining cancer.
AI-generated summary from trial data · Jul 21, 2026 · Not medical advice
France